drugset / Trial / NCT00745498
Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effect of pre- and intra-operative bevacizumab injection on postoperative vitreous hemorrhage after diabetic vitrectomy.
Timeline
- Start
- 2008-06
- Primary completion
- 2010-10
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 1.25 mg | Intravitreal |